Lisdexamfetamine Dimesylate 00406-5111-01
- Manufacturer
- Specgx Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- August 25, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA211840
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 10 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
00406-5111-01Selected100 CAPSULE in 1 BOTTLE (0406-5111-01)